Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
March 2, 2026
Health
-
-
OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry
February 27, 2026
-
Healthcare Triangle Subsidiary QuantumNexis Inc. Launches its Dubai, UAE Operations to accelerate Digital Health Transformation across the GCC Countries
February 27, 2026
-
OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers
February 26, 2026
-
Avalon GloboCare’s Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media Infrastructure
February 26, 2026
-
Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
February 26, 2026
-
Sharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana Ecosystem
February 25, 2026
-
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
February 25, 2026
-
Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
February 25, 2026
-
ECGI Holdings and Nomyx Begin Live Pilot to Tokenize Up to $10 Million in Mortgage Loans on RezyFi
February 24, 2026
-
OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers
February 24, 2026
-
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
February 24, 2026
-
Solana Company (NASDAQ: HSDT) Announces Plan for the Pacific Backbone, a High-Speed Infrastructure Buildout for Solana
February 23, 2026
-
Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion
February 23, 2026
-
Prenetics Launches IM8 Daily Ultimate Essentials PRO – A Clinical Formula with Two New Flavours
February 23, 2026
-
Allurion Receives U.S. FDA Approval
February 23, 2026